Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $517.49, denoting a -1.23% move from the preceding trading day.
Equity
Vertex Pharmaceuticals Incorpor (VRTX) Stock — Today's Move
$517.49
$-6.44 today
VRTX is down 1.23% today. Volume is 1.14M vs a 30-day average of 1.18M (0.97x).
Day High
$529.66
Day Low
$509.33
Open
$526.86
Prev Close
$523.93
Volume
1.14M
Avg Vol (30d)
1.18M
52-Wk High
$560.25
52-Wk Low
$403.16
Sector
—
Today's Move
-1.23%
Next Earnings
Mon, Nov 2 · after close
Vertex Pharmaceuticals Incorpor is scheduled to report earnings Mon, Nov 2, 2026 · after close. Analysts expect EPS of $4.86 on revenue of about $3.48B. Stocks often move sharply on earnings day.
52-wk low $403.1652-wk high $560.25
VRTX is 73% of the way from its 52-week low to its high.
Indicators:
Close price · volume bars (dashed line = average volume) · news that day (2M–1Y) — hover or tap the chart. Indicators are for education, not trading advice.
Why is VRTX moving today?
The $500 Million Non-CF Factor Vertex Investors Can’t Ignore on Nov. 2
Vertex Pharmaceuticals (NASDAQ:VRTX) reports third-quarter results on Nov. 2. Cystic fibrosis still pays the bills, but I’ll be watching whether CASGEVY and JOURNAVX stay on pace …
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vertex Pharmaceuticals (VRTX) Posts Positive Phase 3 Results For Povetacicept
Vertex Pharmaceuticals (NasdaqGS:VRTX) reported positive Phase 3 results for povetacicept in IgA nephropathy, meeting all key endpoints. The late stage data are set to be publishe…
Related Movers
XP
▼ -48.36%
XP Inc.
Gap Stock Movers: SGRY Leads Gap-Ups and XP Leads Gap-Downs in Today's Session
$15.71
-$14.71
INTR
▼ -34.91%
Inter & Co. Inc.
$4.68
-$2.51
BBD
▼ -28.01%
Banco Bradesco Sa
Most Active Stocks on Oct. 26: RCT, NU and BBD Top Volume
$2.93
-$1.14
SBS
▼ -26.09%
Companhia de saneamento Basico
$4.73
-$1.67
FAQ — VRTX
Why is VRTX moving today?
VRTX is down 1.23% in the current session. Scroll to the news section below to see the most recent headlines and catalysts driving the move.
Is Vertex Pharmaceuticals Incorpor a good stock to buy today?
WeeklyTrader.io does not provide financial advice. Always verify catalysts, assess risk, and conduct your own research before making any investment decision.
What is VRTX's average volume?
Average volume for VRTX is approximately 1.18M shares per day based on the trailing 30 sessions.